Ambey Laboratories IPO GMP Today in the Grey Market is Not Available at The Moment. Investors are Advised to Closely Monitor Market Trends and consult Reliable Sources for the Most up-to-date Information. It is important to Exercise Caution and Conduct Thorough Research Before Making Any Investment Decisions.
About Ambey Laboratories IPO-
How Much GMP Price Ambey Laboratories IPO today?, live Grey Market Premium Kostak Rates today live Ambey Laboratories IPO Now. Subject to sauda Rate today, Ambey Laboratories IPO as of today Subject to sauda rates kostak.
Ambey Laboratories IPO is to open on 4 July, 2024. Ambey Laboratories is a SME IPO to Raise 6,864,000 shares (Approx ₹46.68 Cr) Via IPO. The Ambey Laboratories IPO Price Band is Fixed At ₹68 Per Every Share With a IPO Lot Size of 2000 Shares.
About Ambey Laboratories Data Like –
- Arpit Gupta is the CEO of Ambey Laboratories and Ambey Laboratories was founded in the year 1985 and has just completed 35 years in operation.
- Ambey Laboratories is manufacturer and supplier of “2, 4-D base chemicals” with highest quality practice and compliant with Highest Environmental, Health, and Safety (EHS) in chemical industry. The company has Programmable Logic Controller (PLC) and Supervisory Control along with Quality Assurance Department which ensurestesting through HPLC, GC, UV etc.
- At every stage of production at our manufacturing facility installed, integrated and operating at 5 Acres Facility in the region of Behror, Rajasthan, India for manufacturing of “2, 4-D base chemicals”.
- Our company has obtained certificate of compliance from RoHS Directive (2015/863/EC) European Parliament and commission decision (2005/618/EC) on the restriction of use of certain Hazardous Substance [Lead (Pb), Mercury (Hg), Cadmium (Cd), Hexavalent Chromium (Cr6+), Polybrominated Biphenyls (PBBs) and phthalate (DBP), Diisobutyl phthalate (DIBP)] ethers (PBDEs) in Electrical and Electrical Equipments. Due to backward integration of our products, our plant is ZLD (Zero Liquid Discharge) to ensure minimumand supply sustainability to our valued customers.
Ambey Laboratories IPO GMP With Per Lot Profit
| DATE | IPO GMP PRICE | EST LISTING PRICE |
|---|---|---|
| 10 July | ₹36 | ₹104 |
| 9 July | ₹36 | ₹104 |
| 8 July | ₹36 | ₹104 |
| 7 July | ₹45 | ₹113 |
| 6 July | ₹45 | ₹113 |
| 5 July | ₹42 | ₹109 |
| 4 July | ₹42 | ₹109 |
| 3 July | ₹35 | ₹103 |
| 2 July | ₹26 | ₹94 |
| 1 July | ₹23 | ₹91 |
| 30 June | ₹0 | ₹68 |
| 29 June | ₹0 | ₹68 |
| 28 June | ₹0 | ₹68 |
Also Read : Ambey Laboratories IPO details, Date, Price, GMP, Review,
Latest IPO GMP
We Update live GMP status of all upcoming IPOs every day until the IPO gets listed on the stock exchange. You can easily see the GMP price of all IPOs on our IPO GMP dashboard. We update IPO GMP performance regularly on Moneymintidea.com. You can easily get a rough idea of the GMP of all IPOs and what the listing price of the IPO is going to be.
IPO Grey Market Premium (GMP)
Before investing money in any IPO, one should pay more attention to the fact that the IPO GMP price is very volatile, if you are thinking of investing in Ambey Laboratories IPO by looking at the GMP price, then your decision may prove to be quite risky. Before investing in a new IPO, you should have good knowledge about the business of the company. It should be your decision whether to invest in Ambey Laboratories IPO or not and not by looking at the GMP price of the IPO.
Grey Market Premium (GMP) is the price at which an IPO is traded in an informal/unregulated manner before getting listed on the stock exchange. GMP price in the gray market reflects the price at which a company’s IPO is listed. Going to do. A good GMP premium/price gives you an indication of how much profit the IPO will make upon listing. Rather, if the GMP premium of an IPO is negative, then one should avoid investing money in that IPO.
Disclaimer:- The article here should not be construed as an offer to you to buy or sell based on any IPO / Gray Market Premium (GMP) or as advice in any way. The article here is written for informational and educational informational purposes only. This article should not be relied upon for investing in IPOs. Readers should consult a qualified financial advisor before making investment decisions.
Any reader making any investment decision based on the information published here does so entirely at his own risk. Investors should be aware that any investment in the equity market is subject to unpredictable market-related risks. The author does not intend to invest in this offering.
